Medical and Pharmaceutical AstraZeneca shares slide on disappointing lung cancer drug trial results "Dato-DXd" was thought to have immense potential but now appears to be a disappointment Rowan DunneSeptember 10, 2024
Medical and Pharmaceutical First-ever global lung cancer vaccine trial kicks off in the UK It uses the same mRNA technology as the COVID vaccine Rowan DunneAugust 30, 2024
Medical and Pharmaceutical Eledon Pharma completes first pig-to-human kidney transplant using Tegoprubart Historic kidney xenotransplantation procedure conducted at Massachusetts General Hospital Zartasha MushtaqMarch 23, 2024
Psychedelics Alberta university kicks off major study on psilocybin for alcohol use disorder treatment Filament Health will supply psilocybin for what University of Calgary says is Canada's 'largest single-site clinical trial' of its kind Rowan DunneMarch 21, 2024
AI and Autonomy NetraMark demonstrates efficacy of AI to help with clinical trials AI analyzes huge amounts of data, finds patterns, and makes decisions on its own Joseph MortonMarch 11, 2024
Cannabis CBD relieves anxiety better than THC without paranoia, study shows The CU Boulder researchers found that cannabis generally helps alleviate anxiety, but CBD is safer than THC is Rowan DunneFebruary 27, 2024
AI and Autonomy HumanFirst connects clinical researchers to vital data using artificial intelligence-based platform HumanFirst's platform offers cost reduction and risk mitigation for trial portfolios Joseph MortonSeptember 7, 2023
Psychedelics Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010 Rowan DunneAugust 10, 2023
News PharmAla Biotech receives guidance on new MDMA-like drug for PTSD and Autism The MHRA has confirmed that PharmAla's MDMA-like drug candidate ALA-002 does not require additional preclinical data Natalia Buendia CalvilloJuly 20, 2023
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023